- Home
- Equipment
- netherlands
- clinical trial assay development
Refine by
Clinical Trial Assay Development Equipment Supplied In Netherlands
6 equipment items found
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Pelabresib (CPI-0610) is an investigational selective small-molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. The compound has demonstrated a wide therapeutic window, with activity seen at a 48 mg dose in a lymphoma study and with a maximum ...
Manufactured by:Hospitainer based inVaassen, NETHERLANDS
The mobile primary health care (PHC) clinic is specifically developed to reach people who don’t have acces to primary health care. The complete clinic weights less than 3,5 ton and can be driven by anyone who has a driver license. The unit is prepared for independent use and includes a generator, airconditioning, sink, supply and waste water tank. Also a sun shade cover is included to ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The methylation assay pipeline of Self-screen has now been extended with the Precursor-M Gold assay. The newly developed Precursor-M Gold assay is currently available for Research Use Only indications. Precursor-M Gold demonstrates very good clinical performance in the detection of high grade precursor stadia and cervical cancer among HPV positive women. The assay is ready for further IVD ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas ...
Manufactured by:ViciniVax BV based inGroningen, NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...
Manufactured by:Illumina Inc. based inSan Diego, CALIFORNIA (USA)
The NextSeq 550Dx instrument is FDA regulated and CE-in vitrodiagnostic (IVD) marked, enabling clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using targeted panels, to clinical research applications that include methods from targeted panels to whole ...